Thanks for sharing that article, Guti. It seems abundantly clear that local interferon gamma production is essential to get responses. There is a very strong correlation between interferon gamma fold change and response/nonresponse. It is interesting to see them use a p40 MAB in their study.
In terms of nonresponders to Immunopulse IL-12 in combination with Pembro... do these patients have more p40 expression on tumor cells? Or is it CTLA-4 outcompeting CD28? Or is it limited intratumoral IL-12 expression, perhaps owing to tumor heterogeneity? Or, is it just a matter of pseudoprogression? I think some of these questions will be addressed this week and we will have a better sense of why some patients respond (and respond very well) and some don't.